SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is seeing heightened market attention driven by ongoing institutional adoption of its oracle services and increased anticipation surrounding the integration of tokenized real-world assets. Community sentiment remains mixed, with vocal bulls focusing on the project's long-term infrastructure value and potential for RWA-led growth, while others express frustration over extended periods of price stagnation compared to other market sectors.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom shares are facing selling pressure following a Bank of America report highlighting significant off-balance-sheet debt obligations linked to its AI financing vehicle and investor anxieties over gross margins. Despite the short-term noise, the community remains divided between those viewing the pullback as a buying opportunity in a fundamental leader and others wary of technical rejections and broader sector valuation concerns.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing intense community debate, with bulls viewing current price levels as a rare accumulation opportunity driven by strong technological fundamentals and real-world utility, while bears express frustration over stagnant price action and concerns regarding tokenomics. The discussion centers on whether the current weakness is a temporary cyclical downturn or a sign of deeper structural decline compared to other sector leaders.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing significant volatility and aggressive trading as investors capitalize on leveraged exposure to gold miners, with community sentiment divided between capitalizing on current momentum and cautious profit-taking. Traders are heavily debating the sustainability of the recent rally, with many monitoring gold price technicals and broader market macro-indicators to guide their entry and exit strategies.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as institutional investors and the community closely monitor its strong momentum and recent breakout performance. Traders are actively discussing the company's improved profitability, successful membership growth, and potential for further gains as it continues to execute on its long-term health-tech growth story.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending as investors debate the stock's sharp pullback despite a record-breaking earnings beat and robust AI-focused guidance. The community is deeply divided, with some attributing the volatility to institutional manipulation and algorithmic trading, while bullish long-term investors are viewing the decline as a prime buying opportunity tied to an emerging networking supercycle.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an earnings beat that revealed a shift back to net stock purchasing, including a significant stake in Alphabet, signaling a return to capital deployment. While some investors remain skeptical about the firm's growth prospects and succession planning, many in the community are debating the company's defensive value proposition compared to high-growth tech stocks.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is currently in focus as investors analyze the firm's recent launch of AI-powered investment tools and professionally managed bond portfolios ahead of its upcoming earnings report. The stock is generating significant community debate, with bulls highlighting the potential for institutional accumulation and short squeezes, while bears remain skeptical, often pointing to historical performance trends and broader sector volatility.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run is capturing market attention following a strong earnings report that highlighted a massive increase in contracted revenue and an expanding GPU infrastructure pipeline. Community discourse remains divided between investors betting on the company's long-term potential as an AI cloud infrastructure play and those concerned about short-term volatility stemming from warrant redemption dynamics and lock-up expiration.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest the company's recent breakthrough Phase 3 results for daraxonrasib in pancreatic cancer, which demonstrated a significant survival benefit that has solidified the drug's position as a potential new standard of care. The community is actively discussing the stock's massive market capitalization and its status as a top buyout target for major pharmaceutical companies looking to replace revenue from patent cliffs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 results 2026: BHEL to Paytm among firms to declare Q4 earnings next week

… Fincorp 11 Ajanta Pharma 12 Emcure Pharmaceuticals 13 Aadhar Housing … Kriti Nutrients 46 Jenburkt Pharma 47 Kriti Industries (India) … Coast Hotels 61 Sandu Pharmaceuticals 62 Premier Energy and … STL Networks 39 Shukra Pharmaceuticals 40 Alldigi Tech 41 …

Shukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics, Cancer Therapy Tech

Greater Noida: Shukra Pharmaceuticals Ltd. has received a Letter … . In a parallel development, Shukra Pharmaceuticals has signed a Memorandum of … and Managing Director of Shukra Pharmaceuticals Ltd., reiterated the company’s …

Shukra Pharma gets YEIDA LoI for Rs 600-crore facility

Shukra Pharmaceuticals will establish a Rs 600-crore facility in Greater Noida. This plant will produce advanced surgical robotics and BNCT technology. The project aims to create over 900 direct jobs. A partnership with Borns Medical Robotics Inc. will bring surgical robotics to India. This venture seeks to make high-precision surgery affordable and accessible across India and Asia.

Pharma firm set to invest Rs 587cr in Medical Device Park

Noida: Yamuna Expressway Industrial Development Authority (YEIDA) has issued a letter of intent (LoI) to Shukra Pharmaceuticals for setting up an adva.

Shukra Pharma Partners With US Firm to Bring AI Surgical Robots to India

… and enhance healthcare infrastructure Shukra Pharmaceuticals , through its subsidiary Shukra Robotics … robotics and AI, while Shukra Pharma will leverage its regulatory knowledge … . On the financial front, Shukra Pharma reported a consolidated net profit …

Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India

… Ltd., a subsidiary of Shukra Pharmaceuticals Limited. Under the proposed association … and AI-enabled technologies, Shukra Pharmaceuticals will leverage its established presence … global surgical robotics market. Shukra Pharmaceuticals clarified that the MoU is …

Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.

Current Price	41.00
Prev Close	N/A
Open	42.04
Dividend Yield	N/A
50-Day Moving Average	41.42
Beta	0.00
Avg. Volume	0.00
PE Ratio	53.50

52-Week High	43.40
52-Week Low	40.06
Market Capitalization	18.13B
EPS (Annual)	0.50
Price to Book	27.56
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info